Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Beta Bionics (BBNX) Non Operating Income (2024 - 2026)

Beta Bionics' Non Operating Income history spans 3 years, with the latest figure at $2.4 million for Q1 2026.

  • On a quarterly basis, Non Operating Income rose 123.73% to $2.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $10.9 million, a 178.51% increase, with the full-year FY2025 number at -$1.5 million, up 84.02% from a year prior.
  • Non Operating Income hit $2.4 million in Q1 2026 for Beta Bionics, down from $2.7 million in the prior quarter.
  • Over the last five years, Non Operating Income for BBNX hit a ceiling of $3.0 million in Q2 2025 and a floor of -$10.0 million in Q1 2025.
  • Historically, Non Operating Income has averaged -$663444.4 across 3 years, with a median of $1.2 million in 2024.
  • The widest YoY moves for Non Operating Income: up 150250.0% in 2025, down 234.25% in 2025.
  • Tracing BBNX's Non Operating Income over 3 years: stood at -$5.1 million in 2024, then skyrocketed by 152.42% to $2.7 million in 2025, then fell by 10.61% to $2.4 million in 2026.
  • Business Quant data shows Non Operating Income for BBNX at $2.4 million in Q1 2026, $2.7 million in Q4 2025, and $2.8 million in Q3 2025.